Insacef 500 Tablet DT contains Cefuroxime 500mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefuroxime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is formulated as a dispersible tablet (DT), allowing for ease of administration, particularly in patients with difficulty swallowing. Insacef 500 Tablet DT demonstrates good oral bioavailability and achieves therapeutic concentrations in various body tissues and fluids. It is generally well tolerated, with common adverse effects including gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be individualized based on the severity of infection, renal function, and patient age. It is essential to complete the full prescribed course to prevent the development of resistance. Insacef 500 Tablet DT should be used under medical supervision, and caution is advised in patients with renal impairment or a history of gastrointestinal disease.